The Rajasthan government has officially revoked the license of a pharmaceutical firm in Kota following a rigorous investigation into a series of tragic post-partum deaths. This decisive action comes amidst mounting concerns regarding medical accountability and safety standards within the regional healthcare supply chain.
Furthermore, the World Health Organization (WHO) has reportedly sought a comprehensive report detailing the incident to assess the broader implications for public health. This move aims to ensure patient safety and restore trust in the pharmaceutical industry while authorities continue their deep-dive inquiry into the tragic circumstances surrounding these unfortunate losses.
